The European Patent Office has released the long-awaited reasoning for its decision to uphold the revocation of a Broad Institute CRISPR/Cas9 patent. In January this year, the EPO’s Board of Appeal concluded that the Broad’s patent, EP2,771,468, lacked novelty due to an invalid claim to priority. The EPO dealt with three questions in its reasoning.
The US Court of Appeals for the Federal Circuit has narrowed the landscape in which patent infringement suits over generic drugs suits can be filed, in a ruling handed down yesterday, November 5.
Australia has secured 40 million doses of a COVID-19 vaccine candidate in a deal with US biotechnology company Novavax.
Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.
Gilead Sciences has claimed that a group of Florida-based healthcare clinics, pharmacies, and lab testing facilities have “wrongfully captured tens of millions of dollars” through a fraudulent programme.
US federal agencies are to step up their cooperation on stemming the flow of counterfeit drugs, medical devices, and dietary supplements into the country through the international mail system.
Health technology company Philips has accused Boston Scientific of infringing six patents through the sale of its Polaris guidance system and related medical devices.
Pennsylvania-based E A Fischione Instruments has taken a rival lab instrument manufacturer to court over the alleged theft of trade secrets related to specimen holders for transmission electron microscopes.
French drugmaker Sanofi and US biotechnology company Regeneron have secured a victory at the European Patent Office, which has sided in their favour by ruling that a patent belonging to rival Amgen is invalid.
St. Louis-based Washington University has won more than $31.6 million from a patent victory over the University of Wisconsin’s technology transfer office.